drugset / Trial / NCT00617565
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia. The aim of this trial is to investigate the efficacy of biphasic insulin aspart 30 on postprandial glycaemic control.
Timeline
- Start
- 2003-07-08
- Primary completion
- 2003-11-26
- Completion
- 2003-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | biphasic human insulin | Protein / enzyme biologic | — | — |
| Subject | biphasic insulin aspart | Protein / enzyme biologic | — | — |